We are live on
!
Find out more
Man Group Portfolio holdings
AUM
$55.1B
1-Year Est. Return
24.23%
This Fund
S&P 500
This Quarter
Est. Return
+12.77%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
–
AUM
$52.5B
AUM Growth
+$13.1B
(+33%)
Cap. Flow
+$7.72B
Cap. Flow
% of AUM
14.72%
Top 10 Holdings %
Top 10 Hldgs %
17.31%
Holding
2,462
New
319
Increased
921
Reduced
776
Closed
312
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.09B |
| 2 |
NVIDIA
NVDA
|
+$436M |
| 3 |
Apple
AAPL
|
+$415M |
| 4 |
Microsoft
MSFT
|
+$396M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booz Allen Hamilton
BAH
|
+$120M |
| 2 |
Walt Disney
DIS
|
+$115M |
| 3 |
Wingstop
WING
|
+$89.6M |
| 4 |
Cisco
CSCO
|
+$88.1M |
| 5 |
Amphenol
APH
|
+$84.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.78% |
| 2 | Healthcare | 10.33% |
| 3 | Financials | 10.22% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Industrials | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DAWN
1801
DELISTED
Day One Biopharmaceuticals
DAWN
| $370K | ﹤0.01% |
56,862
+17,950
| +46% | +$123K |
|
1802
Univest Financial
UVSP
$1.23B
| $369K | ﹤0.01% |
+12,292
| New | +$358K |
|
1803
Ferguson
FERG
$44.7B
| $369K | ﹤0.01% |
1,694
-805
| -32% | -$148K |
|
1804
Oceaneering
OII
$5.25B
| $369K | ﹤0.01% |
17,800
-472
| -3% | -$9.1K |
|
1805
OneSpan
OSPN
$562M
| $368K | ﹤0.01% |
22,044
-22,633
| -51% | -$351K |
|
|
THR
1806
DELISTED
Thermon Group Holdings
THR
| $366K | ﹤0.01% |
+13,036
| New | +$353K |
|
1807
First Mid Bancshares
FMBH
$1.36B
| $366K | ﹤0.01% |
9,762
-170
| -2% | -$5.95K |
|
1808
Ero Copper
ERO
$2.71B
| $365K | ﹤0.01% |
+21,662
| New | +$293K |
|
1809
CALL
Thermo Fisher Scientific
TMO
$211B
| $365K | ﹤0.01% |
900
-12,100
| -93% | -$5.06M |
|
1810
Ionis Pharmaceuticals
IONS
$9.35B
| $354K | ﹤0.01% |
8,969
-1,064
| -11% | -$34.8K |
|
1811
Embecta
EMBC
$195M
| $349K | ﹤0.01% |
36,002
+7,339
| +26% | +$82.6K |
|
1812
Element Solutions
ESI
$9.12B
| $349K | ﹤0.01% |
15,393
-81,029
| -84% | -$1.7M |
|
1813
Ezcorp Inc
EZPW
$1.82B
| $347K | ﹤0.01% |
+25,017
| New | +$362K |
|
1814
Cathay General Bancorp
CATY
$4.2B
| $347K | ﹤0.01% |
+7,623
| New | +$324K |
|
1815
Tidewater
TDW
$3.91B
| $343K | ﹤0.01% |
7,443
-7,191
| -49% | -$291K |
|
1816
Liberty Latin America Class C
LILAK
$1.5B
| $343K | ﹤0.01% |
+60,651
| New | +$297K |
|
1817
Unisys
UIS
$227M
| $340K | ﹤0.01% |
74,972
-40,371
| -35% | -$181K |
|
1818
Andersons Inc
ANDE
$2.65B
| $339K | ﹤0.01% |
9,222
-32,697
| -78% | -$1.2M |
|
1819
OP Bancorp
OPBK
$233M
| $339K | ﹤0.01% |
+26,073
| New | +$318K |
|
1820
Eton Pharmaceutcials
ETON
$1.17B
| $338K | ﹤0.01% |
23,754
+1,350
| +6% | +$21.3K |
|
1821
Phibro Animal Health
PAHC
$1.38B
| $337K | ﹤0.01% |
13,176
-742
| -5% | -$16.2K |
|
|
BAND
1822
Bandwidth Inc
BAND
$1.91B
| $336K | ﹤0.01% |
21,132
+9,158
| +76% | +$124K |
|
1823
ARKO Corp
ARKO
$890M
| $333K | ﹤0.01% |
+78,838
| New | +$344K |
|
1824
Stagwell
STGW
$1.84B
| $330K | ﹤0.01% |
73,306
+36,779
| +101% | +$185K |
|
|
SNCR
1825
DELISTED
Synchronoss Technologies
SNCR
| $330K | ﹤0.01% |
48,107
-13,616
| -22% | -$113K |
|
Similar funds
Man Group's Q2 2025 Portfolio in Review
As of Q2 2025, Man Group held 2,462 positions worth $52.5B, up 33% from $39.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Man Group deployed $7.72B of net new capital in Q2 2025, opening 319 new positions and adding to 921 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,900,024 shares worth $1.17B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Booz Allen Hamilton, an estimated $120M trimmed.
- Man Group's largest Q2 2025 buy was State Street SPDR S&P 500 ETF Trust: 1,900,024 shares worth $1.17B.
- Man Group added most to NVIDIA in Q2 2025, an estimated $436M increase.
- Man Group's biggest Q2 2025 reduction was Booz Allen Hamilton, cutting an estimated $120M.
- Man Group fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $81.9M.
- Man Group's ten largest holdings make up 17% of its $52.5B portfolio in Q2 2025.
- Man Group opened 319 new positions and closed 312 in Q2 2025.
- Man Group's portfolio value rose 33% quarter-over-quarter to $52.5B.
Based on Man Group's 13F filing for Q2 2025, filed 14 Aug 2025.